Systems LLC, a medical technology company, announced that the GammaPod stereotactic radiotherapy system has received CE marking, paving the way for new sales in Europe and offering patients the latest ...
It hasn’t been tried on a single patient yet, and already doctors are calling this new radiation therapy device for breast cancer “paradigm-changing” and “revolutionary.” It’s the GammaPod, coming ...
COLUMBIA, Md., Jan. 9, 2018 /PRNewswire/ -- Xcision Medical Systems, LLC has announced that the GammaPod Stereotactic Radiotherapy System, the world's first noninvasive external beam system optimized ...
A Maryland company can now begin marketing its device, which could change the way breast cancer is treated, after it received government clearance last month. The Food and Drug Administration granted ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Allegheny Health Network (AHN) is one of the first medical ...
Baltimore, Md., Dec. 22, 2017 - The GammaPod ™ - a first-of-its kind stereotactic radiotherapy system to treat early stage breast cancer - has received 510(k) clearance from the U.S. Food and Drug ...
Xcision Medical Systems, LLC has announced that the GammaPod Stereotactic Radiotherapy System, the world's first noninvasive external beam system optimized for partial breast treatments, has received ...
Xcision to Highlight Short, Noninvasive and Patient Friendly Treatment Option at ESTRO 38 in Milan, Italy from April 26-30 "We are excited to bring GammaPod to the European market, where the need for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback